Market Data 
Markets
Replies to post #225572 on Biotech Values
07/15/19 2:58 PM
07/15/19 3:01 PM
In addition to the Company's Phase 2 trial of Bryostatin-1 in advanced AD, Neurotrope has also conducted preclinical studies of Bryostatin-1 as a potential treatment for…Fragile X syndrome, multiple sclerosis, stroke, Niemann-Pick Type C disease, Rett syndrome, and traumatic brain injury. …Bryostatin-1 has already undergone testing in more than 1,500 people in cancer studies…
AI
